HB 2457 — AN ACT to amend Tennessee Code Annotated, Title 4; Title 56 and Title 71, relative to the coverage of long-acting injectable drugs for the treatment or prevention of human immunodeficiency virus.
Last action — Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee
-
✓Introduced
-
✓In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has passed the House. Introduced February 02, 2026. It now moves to the second chamber.
Next likely step: consideration and a floor vote in the Senate.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Passed House
Current position in the legislative process.
-
2 sponsors
1 primary, 1 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (2 D).
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
Bill Text
- Full text View text Current pdf
Action History
-
Filed for introduction
-
Refer to Senate Delayed Bills Committee
-
Approved by Delayed Bills Committee
-
Introduced, Passed on First Consideration
-
Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
-
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
-
Assigned to General Subcommittee of Senate Commerce and Labor Committee
-
Filed for introduction
-
Intro., P1C.
-
Sponsor change.
-
P2C, ref. to Insurance Committee
-
Assigned to s/c Tenncare Subcommittee
-
Placed on s/c cal Tenncare Subcommittee for 3/3/2026
-
Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee
Sponsors
- Torrey C. Harris · Primary
- Justin J. Pearson · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 1 co-sponsors · 131 not signed on
Sponsors (1)
- Harris, Torrey C. Democrat
Co-sponsors (1)
- Pearson, Justin J. Democrat
Not signed on (131)
131 members have not signed on to this bill.
Show all 131 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 2457 do?
- TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
- Who sponsors HB 2457?
- HB 2457 is sponsored by Harris, Torrey C. (Democrat) and Pearson, Justin J. (Democrat).
- What is the current status of HB 2457?
- This bill has passed the House. Introduced February 02, 2026. It now moves to the second chamber.
- Where can I track HB 2457?
- Track HB 2457 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 2457
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 2457
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →